Literature DB >> 24943727

Understanding the presence of false-positive antibodies in acute hepatitis.

Sasan Sakiani1, Christopher Koh2, Theo Heller2.   

Abstract

Although false-positive antibodies (FPAs) have been well described in chronic hepatitis C virus (HCV), this has not been evaluated in acute viral hepatitis. Patients with acute viral hepatitis underwent antibody testing for other causes of liver disease and sexually transmitted diseases. Those with antibody positivity underwent confirmatory testing and monitoring. Patients with FPAs were compared with patients with acute hepatitis C infection without FPAs. In total 7 of 24 patients (29%) had FPAs. FPAs during acute viral hepatitis are associated with higher IgM levels and higher ESR in acute HCV. This has both mechanistic and clinical implications and should be evaluated further. Published by Oxford University Press on behalf of the Infectious Diseases Society of America 2014. This work is written by (a) US Government employee(s) and is in the public domain in the US.

Entities:  

Keywords:  acute hepatitis; antibodies; false-positive antibodies; hepatitis C virus; liver

Mesh：

Substances：

Year:  2014        PMID： 24943727      PMCID： PMC4271024          DOI： 10.1093/infdis/jiu348

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


  15 in total

1.  Virus, liver and autoimmunity.

Authors:  D P Bogdanos; G Mieli-Vergani; D Vergani
Journal:  Dig Liver Dis       Date:  2000 Jun-Jul       Impact factor: 4.088

2.  False-Positive Results for Immunoglobulin M Serologic Results: Explanations and Examples.

Authors:  Charles R Woods
Journal:  J Pediatric Infect Dis Soc       Date:  2013-01-17       Impact factor: 3.164

Review 3.  HCV and autoimmunity.

Authors:  S Ferri; L Muratori; M Lenzi; A Granito; F B Bianchi; D Vergani
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

Review 4.  Unusual aspects of acute Q fever-associated hepatitis.

Authors:  S H Yale; P C de Groen; J D Tooson; P J Kurtin
Journal:  Mayo Clin Proc       Date:  1994-08       Impact factor: 7.616

5.  Virus-induced autoimmunity in hepatitis C virus infections: a rare event.

Authors:  B M McFarlane; C Bridger; C J Tibbs; M G Saleh; A Fuzio; G Verucchi; L Attard; A Boschi; F Chiodo; I G McFarlane
Journal:  J Med Virol       Date:  1994-01       Impact factor: 2.327

6.  Differential diagnosis of hepatitis E virus, cytomegalovirus and Epstein-Barr virus infection in patients with suspected hepatitis E.

Authors:  M Fogeda; F de Ory; A Avellón; J M Echevarría
Journal:  J Clin Virol       Date:  2009-06-07       Impact factor: 3.168

7.  False-positive tests for syphilis associated with human immunodeficiency virus and hepatitis B virus infection among intravenous drug abusers. Valencian Study Group on HIV Epidemiology.

Authors:  I Hernández-Aguado; F Bolumar; R Moreno; F J Pardo; N Torres; J Belda; A Espacio
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-11       Impact factor: 3.267

8.  Acute liver failure: Summary of a workshop.

Authors:  William M Lee; Robert H Squires; Scott L Nyberg; Edward Doo; Jay H Hoofnagle
Journal:  Hepatology       Date:  2008-04       Impact factor: 17.425

9.  High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C.

Authors:  B D Clifford; D Donahue; L Smith; E Cable; B Luttig; M Manns; H L Bonkovsky
Journal:  Hepatology       Date:  1995-03       Impact factor: 17.425

10.  Prevalence of non-organ-specific autoantibodies and chronic liver disease in the general population: a nested case-control study of the Dionysos cohort.

Authors:  M Lenzi; S Bellentani; G Saccoccio; P Muratori; F Masutti; L Muratori; F Cassani; F B Bianchi; C Tiribelli
Journal:  Gut       Date:  1999-09       Impact factor: 23.059
View more
  7 in total

1.  Reply to Tennant and Post.

Authors:  Sasan Sakiani; Christopher Koh; Theo Heller
Journal:  J Infect Dis       Date:  2015-08-19       Impact factor: 5.226

2.  A retrospective analysis of the application of the Elecsys® HIV combi PT assay in southern China.

Authors:  Shaocong Liang; Guihua Deng; Shaosong Zhou; Jing Zeng; Weiqing Tan; Xiaopeng Yuan
Journal:  J Clin Lab Anal       Date:  2017-06-26       Impact factor: 2.352

Review 3.  Immunoglobulin M for Acute Infection: True or False?

Authors:  Marie Louise Landry
Journal:  Clin Vaccine Immunol       Date:  2016-07-05

4.  Seroprevalence of transfusion-transmissible infections among blood donors at National Blood Transfusion Service, Eritrea: a seven-year retrospective study.

Authors:  Nejat Siraj; Oliver Okoth Achila; John Issac; Efrem Menghisteab; Maedn Hailemariam; Semere Hagos; Yosan Gebremeskel; Daniel Tesfamichael
Journal:  BMC Infect Dis       Date:  2018-06-07       Impact factor: 3.090

5.  Hepatitis virus (HCV) diagnosis and access to treatment in a UK cohort.

Authors:  Emily Adland; Gerald Jesuthasan; Louise Downs; Victoria Wharton; Gemma Wilde; Anna L McNaughton; Jane Collier; Eleanor Barnes; Paul Klenerman; Monique Andersson; Katie Jeffery; Philippa C Matthews
Journal:  BMC Infect Dis       Date:  2018-09-14       Impact factor: 3.090

6.  Heterologous Immunity between Adenoviruses and Hepatitis C Virus (HCV): Recombinant Adenovirus Vaccine Vectors Containing Antigens from Unrelated Pathogens Induce Cross-Reactive Immunity Against HCV Antigens.

Authors:  Babita Agrawal; Nancy Gupta; Satish Vedi; Shakti Singh; Wen Li; Saurabh Garg; Jie Li; Rakesh Kumar
Journal:  Cells       Date:  2019-05-26       Impact factor: 6.600

7.  Clinical presentations of Hepatitis E: A clinical review with representative case histories.

Authors:  Abhishek Chauhan; Gwilym Webb; James Ferguson
Journal:  Clin Res Hepatol Gastroenterol       Date:  2019-02-23       Impact factor: 2.947
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.